EligibleTrials

Ultrasound-guided Stellate Ganglion Block for Treatment of Chronic Migraine in Adult

Recruiting · NCT06322407 · Interventional (participants receive a specific treatment) · Lead sponsor: Beijing Tiantan Hospital

View the official record on ClinicalTrials.gov →
Migraine

Interventions studied

Stellate Ganglion Block (SGB)standardized drug treatment

What this trial is about

To assess the 6-months effects and safety of stellate ganglion block(SGB) for Chronic Migraine (CM) patients who failure to undergo preventive therapy and are seeking a more suitable non-pharmacological therapy.

Who can take part

Age range
18 Years to 65 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.